Drugs / MF59-eH1N1_f
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT00996307 | Oct → Dec 2009 | influenza | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2/3 | NCT00973349 | Sep → Nov 2009 | influenza | Novartis | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00973700 | Aug → Oct 2009 | swine influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-eH1N1_f | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00973700 ↗ |
| Modality | Vaccine | “Influenza Virus Vaccine” NCT00973349 ↗ |